719 ORAL Randomized, multicenter, phase 3 study of 1st-line irinotecan + 5FU/folinic acid vs cisplatin + 5FU in patients with advanced gastric cancer — quality of life analysis
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.